240405-20-3
Chemical Structure
2,3-Dinor-11beta-prostaglandin F2alpha
Synonym(s): BPG; 2,3-Dinor-11β-PGF2α; 2,3-dinor-11-epi PGF2α
- CAS No.: 240405-20-3
- Formula:C18H30O5
- Molecular Weight:326.43
IUPAC Name: (Z)-5-((1R,2R,3S,5S)-3,5-dihydroxy-2-((S,E)-3-hydroxyoct-1-en-1-yl)cyclopentyl)pent-3-enoic acid
InChIKey: IDKLJIUIJUVJNR-KSJYGFEGSA-N
SMILES: O=C(O)C/C=C\C[C@@H]1[C@@H](/C=C/[C@@H](O)CCCCC)[C@@H](O)C[C@@H]1O
Biological Activity: 2,3-Dinor-11beta-prostaglandin F2alpha (2,3-Dinor-11β-PGF2α) is a metabolite of PGD2. Urinary excretion of 2,3-Dinor-11beta-prostaglandin F2alpha is increased in patients with mast cell activation disease (MCAD) and has been used as a marker of increased PGD2 levels. 2,3-Dinor-11beta-prostaglandin F2alpha levels are also increased in the urine of patients with asthma and are positively correlated with impaired lung function.
| Cat. No. | Product Name | Purity | Description | Pricing | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
2,3-Dinor-11beta-prostaglandin F2alpha | 2,3-Dinor-11beta-prostaglandin F2alpha (2,3-Dinor-11β-PGF2α) is a metabolite of PGD2. Urinary excretion of 2,3-Dinor-11beta-prostaglandin F2alpha is increased in patients with mast cell activation disease (MCAD) and has been used as a marker of increased PGD2 levels. 2,3-Dinor-11beta-prostaglandin F2alpha levels are also increased in the urine of patients with asthma and are positively correlated with impaired lung function. | |||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
2,3-Dinor-11β-prostaglandin F2α-d9 | 2,3-Dinor-11β-prostaglandin F2α-d9 is the deuterium labeled 2,3-Dinor-11β-prostaglandin F2α. | |||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||